Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study

被引：0

作者：

Fung, J. ^{[1
]}

Saliba, F. ^{[1
]}

Kaiser, G. ^{[1
]}

De Carlis, L. ^{[1
]}

Metselaar, H. ^{[1
]}

Nevens, F. ^{[1
]}

Duvoux, C. ^{[1
]}

De Simone, P. ^{[1
]}

Fischer, L. ^{[1
]}

Dong, G. ^{[1
]}

Rauer, B. ^{[1
]}

Junge, G. ^{[1
]}

机构：

[1] H2304E1 Study Grp, Cleveland, OH USA

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

2187

引用

页码：180 / 180

页数：1

共 50 条

[1] EVEROLIMUS WITH REDUCED TACROLIMUS PRESERVES LONG-TERM RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS: 36 AND 48 MONTHS RESULTS FROM THE H2304E1 STUDY
Saliba, F.
Durand, F.
Neau-Cransac, M.
Hardwigsen, J.
Pageaux, G.
Lopez, P.
Dong, G.
Di Giambattista, F.
Duvoux, C.
TRANSPLANT INTERNATIONAL, 2016, 29 : 7 - 7
[2] Everolimus With Reduced Tacrolimus Preserves Long-Term Renal Function in Liver Transplant Recipients: 36 and 48 Months Results From The H2304E1 Study
Fung, J.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
Nevens, F.
Duvoux, C.
De Simone, P.
Fischer, L.
Dong, G.
Rauer, B.
Junge, G.
TRANSPLANTATION, 2014, 98 : 180 - 180
[3] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
TRANSPLANTATION, 2014, 98 : 710 - 710
[4] Efficacy and Safety of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients: Long-Term Results From the H2304E1 Study.
Duvoux, C.
Saliba, F.
Kaiser, G.
De Carlis, L.
Metselaar, H.
De Simone, P.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 710 - 710
[5] The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.
De Simone, P.
Kaiser, G. M.
De Carlis, L.
Metselaar, H. J.
Duvoux, C.
Nevens, F.
Fischer, L.
Fung, J.
Dong, G.
Rauer, B.
Junge, G.
Saliba, F.
LIVER TRANSPLANTATION, 2014, 20 : S106 - S106
[6] Long-Term Superior Renal Function With Everolimus and Reduced Tacrolimus in Liver Transplant Recipients: 3-Year Results from the H2304 Extension Study
Fischer, Lutz
Saliba, Faouzi
Kaiser, Gernot M.
De Carlis, Luciano
Metselaar, Herold J.
Nevens, Frederik
Duvoux, Christophe
Dong, Gaohong
Rauer, Barbara
Junge, Guido
LIVER TRANSPLANTATION, 2014, 20 : S171 - S172
[7] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
De Simone, P.
Nevens, F.
De Carlis, L.
Metselaar, H. J.
Beckebaum, S.
Saliba, F.
Jonas, S.
Sudan, D.
Fischer, L.
Foltys, D.
Koneru, B.
Wang, Y.
Hexham, J. M.
Junge, G.
Fung, J.
LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
[8] Effects of Everolimus and Tacrolimus Exposure on Efficacy and Renal Function in Liver Transplant Recipients at 24 Months in a Randomized Trial (H2304)
Fischer, L.
Kaiser, G.
Koneru, B.
Toselli, L.
Durand, F.
Heaton, N.
Shetty, K.
Dong, G.
Lopez, P.
Junge, G.
Kovarik, J.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 117 - 118
[9] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study
Saliba, Faouzi
Kaiser, Gernot M.
De Carlis, Luciano
Metselaar, Herold J.
De Simone, Paolo
Duvoux, Christophe
Nevens, Frederik
Fischer, Lutz
Fung, John J.
Dong, Gaohong
Rauer, Barbara
Junge, Guido
HEPATOLOGY, 2013, 58 (06) : 1383A - 1383A
[10] EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY
Saliba, F.
Duvoux, C.
Durand, F.
Neau-Cransac, M.
Hardwigsen, J.
Pageaux, G.
Di Giambattista, F.
TRANSPLANT INTERNATIONAL, 2015, 28 : 18 - 18

← 1 2 3 4 5 →